BioLineRx Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K, filed on May 23, 2025, by BioLineRx Ltd., a foreign private issuer based in Modi'in, Israel, serves as a notification of an upcoming Annual Meeting of Shareholders. The filing does not contain financial results or operational updates for a specific reporting period but rather announces corporate governance activities.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice and does not include financial statements or key performance indicators.
Material Changes
No material changes to financial position or operations are reported in this filing. The primary content is the scheduling of the Annual General Meeting.
Guidance, Outlook, and Corporate Actions
- Annual Meeting: Scheduled for June 29, 2025, at 3:00 p.m. Israel time.
- Location: BioLineRx Ltd. offices, Modi'in Technology Park, 2 HaMa'ayan Street, Modi'in 7177871, Israel.
- Documents: The Notice of Annual General Meeting, Proxy Statement, Proxy Card, and Voting Instruction Form for American Depositary Shareholders are attached as Exhibits 99.1, 99.2, and 99.3.
- Management Commentary: No strategic outlook or risk factors are discussed in this specific filing.
Key Facts for Investor Verification
- Verify the date and time of the Annual Meeting (June 29, 2025, 3:00 p.m. Israel time).
- Review the attached Proxy Statement (Exhibit 99.1) for specific agenda items and proposals to be voted on.
- Confirm voting procedures for American Depositary Shareholders via the attached Voting Instruction Form (Exhibit 99.3).
- Note that this filing contains no financial data; investors should refer to the most recent Form 20-F or quarterly reports for financial metrics.